Naser Farhadi

473 total citations
17 papers, 388 citations indexed

About

Naser Farhadi is a scholar working on Endocrine and Autonomic Systems, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Naser Farhadi has authored 17 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrine and Autonomic Systems, 5 papers in Pathology and Forensic Medicine and 4 papers in Molecular Biology. Recurrent topics in Naser Farhadi's work include Circadian rhythm and melatonin (10 papers), Multiple Sclerosis Research Studies (5 papers) and Stress Responses and Cortisol (3 papers). Naser Farhadi is often cited by papers focused on Circadian rhythm and melatonin (10 papers), Multiple Sclerosis Research Studies (5 papers) and Stress Responses and Cortisol (3 papers). Naser Farhadi collaborates with scholars based in Iran, Lebanon and France. Naser Farhadi's co-authors include Majid Ghareghani, Kazem Zibara, Jamshid Mohammadi, Hamdollah Delaviz, Bahram Mohammadi, Ghasem Ghalamfarsa, Rüssel J. Reiter, Hossein Sadeghi, Amir Ghanbari and Shahrbanoo Oryan and has published in prestigious journals such as Frontiers in Immunology, Frontiers in Pharmacology and Biomedicine & Pharmacotherapy.

In The Last Decade

Naser Farhadi

16 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naser Farhadi Iran 10 136 96 92 48 46 17 388
Mi‐Ja Kim South Korea 11 55 0.4× 55 0.6× 41 0.4× 17 0.4× 36 0.8× 36 402
Tetsuro Shibakusa Japan 13 59 0.4× 98 1.0× 41 0.4× 65 1.4× 169 3.7× 18 431
Antonio J. López-Gambero Spain 12 71 0.5× 162 1.7× 18 0.2× 49 1.0× 137 3.0× 23 489
Daniela Vallejo Spain 10 48 0.4× 146 1.5× 40 0.4× 14 0.3× 79 1.7× 18 491
József Kun Hungary 14 71 0.5× 160 1.7× 44 0.5× 29 0.6× 153 3.3× 34 628
Jennifer Rehnelt Germany 6 37 0.3× 129 1.3× 36 0.4× 34 0.7× 165 3.6× 6 717
Li‐You Chen Taiwan 10 76 0.6× 111 1.2× 16 0.2× 18 0.4× 52 1.1× 15 368
Vinicius Pascoal Brazil 11 96 0.7× 236 2.5× 13 0.1× 35 0.7× 80 1.7× 31 565
Yuxin Ma China 15 49 0.4× 113 1.2× 22 0.2× 21 0.4× 127 2.8× 23 578

Countries citing papers authored by Naser Farhadi

Since Specialization
Citations

This map shows the geographic impact of Naser Farhadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naser Farhadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naser Farhadi more than expected).

Fields of papers citing papers by Naser Farhadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naser Farhadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naser Farhadi. The network helps show where Naser Farhadi may publish in the future.

Co-authorship network of co-authors of Naser Farhadi

This figure shows the co-authorship network connecting the top 25 collaborators of Naser Farhadi. A scholar is included among the top collaborators of Naser Farhadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naser Farhadi. Naser Farhadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hassanpour, Hossein, et al.. (2023). Cardiac telomere attrition following changes in the expression of shelterin genes in pulmonary hypertensive chickens. British Poultry Science. 64(3). 370–376. 3 indexed citations
2.
Ghareghani, Majid, Yahya Jand, Naser Farhadi, et al.. (2019). Melatonin Therapy Modulates Cerebral Metabolism and Enhances Remyelination by Increasing PDK4 in a Mouse Model of Multiple Sclerosis. Frontiers in Pharmacology. 10. 147–147. 42 indexed citations
3.
Ghareghani, Majid, Kazem Zibara, Hossein Sadeghi, & Naser Farhadi. (2018). Spasticity Treatment Ameliorates the Efficacy of Melatonin Therapy in Experimental Autoimmune Encephalomyelitis (EAE) Mouse Model of Multiple Sclerosis. Cellular and Molecular Neurobiology. 38(5). 1145–1151. 19 indexed citations
4.
Ghareghani, Majid, Rüssel J. Reiter, Kazem Zibara, & Naser Farhadi. (2018). Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis: A New Mechanistic Pathway. Frontiers in Immunology. 9. 61 indexed citations
5.
Mohammadi, Jamshid, Hamdollah Delaviz, Ghasem Ghalamfarsa, Bahram Mohammadi, & Naser Farhadi. (2017). A review study on phytochemistry and pharmacology applications of Juglans Regia plant. Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review. 11(22). 145–145. 88 indexed citations
6.
Ghareghani, Majid, et al.. (2017). Corticosteroid therapy exacerbates the reduction of melatonin in multiple sclerosis. Steroids. 128. 32–36. 17 indexed citations
7.
Ghareghani, Majid, et al.. (2017). Melatonin therapy reduces the risk of osteoporosis and normalizes bone formation in multiple sclerosis. Fundamental and Clinical Pharmacology. 32(2). 181–187. 30 indexed citations
8.
Ghareghani, Majid, Amir Ghanbari, Naser Farhadi, et al.. (2016). Methylprednisolone improves lactate metabolism through reduction of elevated serum lactate in rat model of multiple sclerosis. Biomedicine & Pharmacotherapy. 84. 1504–1509. 12 indexed citations
9.
Farhadi, Naser, et al.. (2016). Effects of long-term light, darkness and oral administration of melatonin on serum levels of melatonin. Biomedical Journal. 39(1). 81–84. 27 indexed citations
10.
Ghareghani, Majid, Amir Ghanbari, Naser Farhadi, et al.. (2016). Melatonin exacerbates acute experimental autoimmune encephalomyelitis by enhancing the serum levels of lactate: A potential biomarker of multiple sclerosis progression. Clinical and Experimental Pharmacology and Physiology. 44(1). 52–61. 46 indexed citations
11.
Farhadi, Naser, Abbas Doosti, Jamshid Mohammadi, & Réza Mohammadi. (2015). Effects of orally-administered melatonin and long-term exposure to light and dark on serum indices and gene expression of insulin and glucagon in male Wistar rats. Biological Rhythm Research. 46(3). 435–443. 1 indexed citations
13.
Farhadi, Naser, et al.. (2014). Effect of the pre-operative condition on melatonin and its relationship with cytokines. Biological Rhythm Research. 45(4). 603–607. 2 indexed citations
14.
Farhadi, Naser, Shahrbanoo Oryan, & Mohammad Nabiuni. (2014). Serum levels of melatonin and cytokines in multiple sclerosis. Biomedical Journal. 37(2). 90–90. 29 indexed citations
15.
Farhadi, Naser, et al.. (2012). Rapid Diagnosis of acute kidney injury (AKI) associated with cardiac surgery, using the liver type fatty acid binding protein (L-FABP) biomarker. 6(1). 43–50. 1 indexed citations
16.
Farhadi, Naser, et al.. (2008). Role of HLA-B7, B8, B27, and B51 in Protection against Hepatitis B Virus Infection. Iranian journal of medical sciences. 33(4). 209–212. 1 indexed citations
17.
Farhadi, Naser, et al.. (2007). Th1 Cytokine Profiles in Hepatitis C Virus Infected Patients and Their Contribution to Inflammatory Responses. Shiraz E-Medical Journal. 8(1). 0–0. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026